LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL’S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling